MedPath

dark chocolate effect on diabetes treatment process

Not Applicable
Conditions
Diabetes Mellitus type 2.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT2014010716123N1
Lead Sponsor
Vice Chancellor for Research and Technology, Ahvaz Jundishapur University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

no food supplement consumption; body mass index 18.5-29.9; 30-60 years old; using only blood glucose reducing drugs, Metformin and Glibenclamide; willing to participate. Exclusion criteria: no appropriate corporation; any other disease; Obesity (body mass index more than 30); pregnancy and lactating

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting blood glucose. Timepoint: at the first and at the end of intervention period. Method of measurement: Autoanalyzer.;HgA1C. Timepoint: at the first and at the end of intervention period. Method of measurement: Enzymatic method.;LDL. Timepoint: at the first and at the end of intervention period. Method of measurement: Friedewald formula.;TG. Timepoint: at the first and at the end of intervention period. Method of measurement: Autoanalyzer.;HDL. Timepoint: at the first and at the end of intervention period. Method of measurement: Autoanalyzer.;Hs-CRP. Timepoint: at the first and at the end of intervention period. Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath